Omadacycline: a novel aminomethylcycline
Rodrigo M Burgos,1 Keith A Rodvold1,21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Medicine, University of Illinois at Chicago College of Medicine, Chicago, IL, USAAbstract: Tetracyclines have come a long way since they beca...
Main Authors: | Burgos RM, Rodvold KA |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2019-07-01
|
Series: | Infection and Drug Resistance |
Subjects: | |
Online Access: | https://www.dovepress.com/omadacycline-a-novel-aminomethylcycline-peer-reviewed-article-IDR |
Similar Items
-
The Novel Aminomethylcycline Omadacycline Has High Specificity for the Primary Tetracycline-Binding Site on the Bacterial Ribosome
by: Corina G. Heidrich, et al.
Published: (2016-09-01) -
Use of Oral Tetracyclines in the Treatment of Adult Patients with Community-Acquired Bacterial Pneumonia: A Literature Review on the Often-Overlooked Antibiotic Class
by: Monique R. Bidell, et al.
Published: (2020-12-01) -
Omadacycline vs moxifloxacin in adults with community-acquired bacterial pneumonia
by: Antoni Torres, et al.
Published: (2021-03-01) -
Antimicrobial activity of omadacycline in vitro against bacteria isolated from 2014 to 2017 in China, a multi-center study
by: Meng Xiao, et al.
Published: (2020-11-01) -
Investigational and Experimental Drugs for Community-Acquired Pneumonia: the Current Evidence
by: Sellarès-Nadal J, et al.
Published: (2020-11-01)